Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to sign a written consent form as required by the overseeing ethics or review board
- People (male or female) who have had a surgery to bypass, replace, or repair blood vessels in the legs or arms, the main artery in the body (aorta), or the neck arteries (carotid arteries), using one of these specific graft or patch products: Intergard Standard, Hemashield, Intergard Silver, or Intergard Synergy
- People who were at least 18 years old at the time of their surgery
- People whose medical records are available and include at least 3 years of follow-up information after their surgery
Who may not be able to join:
- People who had an active infection in the area where the graft or patch was placed at the time of their surgery (this applies specifically to the Intergard Standard and Hemashield products) (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Director, Clinical Affairs, Getinge
Phone: +1 603 233 7685
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Peripheral Arterial Disease Cohort: Cohort: Percentage of participants meeting primary device patency; Aortic Disease Cohort: Percentage of participants meeting primary device patency; Carotid Artery Disease Cohort: Percentage of participants achieving freedom from occlusion or reintervention; Peripheral Arterial Disease Cohort: Incidence of Major Adverse Limb Events (MALE); Aortic Disease Cohort: Incidence of Major Adverse Event (MAE); Devices with antimicrobial coating: Percentage of participants achieving freedom from infection; Carotid Artery Disease Cohort: Incidence of Major Adverse Even...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.